More FDA Data Integrity and Compliance with CGMP Guidance for Industry finalised
More British Regulatory Authority MHRA criticises Cross Contamination Issue
More Safety Features: EU Commission issues Version 12 of Q&As
More Revision of EMA's Guideline on the Use of Pharmaceutical Water
More Warning Letter for Korean Manufacturer due to Poor Sterile Practices
More New Ph. Eur. Structure of Chapter 3 on Materials and Containers
More Gene Therapeutics - FDA updates Requirements for CMC Information
More Transfusion Transfer of Babesiosis - FDA Draft: Recommendations for Risk Minimization
More FDA Draft Guidance on the risk of Bacterial Contamination of Blood Platelets
More GDP Association updates Code of Practice for the Responsible Person for GDP
More FDA allows greater flexibility for clinical investigators about informed consent
More PIC/S gives ECA the Opportunity to comment on PI 041-1 (Draft 3) - Data Integrity